Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

SZSE:002864.SZ

36.39 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 261.566245.241210.116264.595216.214274.393225.625280.845262.473232.146198.829264.836221.139226.641174.868219.016213.597156.51381.187174.832152.542162.728120.534150.916130.192114.09394.247103.571111.87494.77566.57295.84276.30566.63966.639
Cost of Revenue 103.0291.07779.96113.43873.42111.644114.244117.748101.651102.97985.632124.92583.23892.15869.95287.18881.09955.11629.35356.545.83346.56437.36243.25337.30330.75729.932.64233.2629.56820.46436.82424.58225.80225.802
Gross Profit 158.547154.164130.155151.158142.794162.749111.381163.098160.822129.168113.197139.911137.902134.483104.917131.828132.497101.39751.834118.332106.709116.16483.173107.66392.88983.33664.34770.92978.61365.20746.10859.01851.72440.83740.837
Gross Profit Ratio 0.6060.6290.6190.5710.660.5930.4940.5810.6130.5560.5690.5280.6240.5930.60.6020.620.6480.6380.6770.70.7140.690.7130.7130.730.6830.6850.7030.6880.6930.6160.6780.6130.613
Reseach & Development Expenses 9.5910.5383.7184.5155.1227.3393.289.0765.0382.0792.0418.1132.5541.7091.6518.3281.3192.0581.2667.7981.9371.6241.7182.623.6161.2350.823.2852.1732.74605.4152.5911.2951.295
General & Administrative Expenses 35.964-0.64512.693-21.99831.773-2.87112.194-19.55129.823-3.5529.601-20.54728.215-0.2069.166-11.71310.971-1.5775.9-12.9378.97-3.7788.496-11.2347.518-0.2458.828-13.3035.322-3.7696.757-12.557.3875.8835.883
Selling & Marketing Expenses 118.43394.61887.56294.02392.076102.77472.224105.79199.83281.22775.89292.60486.42286.53167.6487.62777.02864.44633.73477.88272.51772.76858.19874.03463.18657.08943.5846.352.51141.61629.25235.40831.40226.45226.452
SG&A 154.39793.973100.25572.025123.84999.90384.41886.24129.65577.67485.49472.057114.63786.32576.80675.91487.99962.86939.63364.94581.48768.9966.69462.870.70356.84452.40832.99757.83337.84636.00922.85938.78932.69932.699
Other Expenses -33.552-0.1344.975-5.267-0.4870.0150.47739.946-13.63216.7171.232-8.0863.27-3.088-3.668-0.831-0.1972.035-1.4880.619-0.073-2.623-0.727-0.7481.3877.492-0.493-1.033-0.062-0.342-0.0242.181-1.03600
Operating Expenses 130.435123.974104.292118.785110.38125.43688.175135.261121.06196.4788.767118.716103.804104.51380.111112.81891.40277.34141.39102.84285.09385.17370.06389.53176.46770.62253.64460.38461.89951.53337.00441.77239.732.88132.881
Operating Income 35.20832.16630.66236.87434.92938.01625.0425.85439.94430.93426.2922.19236.82328.00625.50416.5941.0724.38812.92915.99523.07432.61214.67322.04317.47616.37511.78710.72618.33213.0918.26816.97112.5217.3977.397
Operating Income Ratio 0.1350.1310.1460.1390.1620.1390.1110.0920.1520.1330.1320.0840.1670.1240.1460.0760.1920.1560.1590.0910.1510.20.1220.1460.1340.1440.1250.1040.1640.1380.1240.1770.1640.1110.111
Total Other Income Expenses Net -1.3-0.1344.975-5.267-0.4870.0150.1280.1370.064-1.245-2.798-0.012.862-1.918-2.969-3.251-0.2222.3670.9981.1241.386-1.0020.8363.1632.44111.1530.5920.1781.555-0.891-0.861.547-0.5320.550.55
Income Before Tax 33.90832.03235.63731.60734.44338.03225.16825.99140.00929.68923.49222.18236.9628.05121.83615.7640.87326.42311.44116.61523.00129.98913.94521.29518.86323.86711.29410.72318.26912.7828.24418.79411.4927.9487.948
Income Before Tax Ratio 0.130.1310.170.1190.1590.1390.1120.0930.1520.1280.1180.0840.1670.1240.1250.0720.1910.1690.1410.0950.1510.1840.1160.1410.1450.2090.120.1040.1630.1350.1240.1960.1510.1190.119
Income Tax Expense 4.063.6544.5794.5774.7984.9733.3552.7855.694.3783.182.2445.2373.5613.431.6156.5513.6371.6022.8892.6764.2481.9592.8762.5993.4811.6810.0972.7122.1361.3542.4761.6911.2171.217
Net Income 29.91828.50631.14726.32929.84932.69321.56223.19533.09924.78820.08220.06230.68624.68217.73913.09733.57322.6069.83913.72520.32625.74111.98718.41916.26420.3869.61310.62615.55710.6466.8916.2959.8086.7126.712
Net Income Ratio 0.1140.1160.1480.10.1380.1190.0960.0830.1260.1070.1010.0760.1390.1090.1010.060.1570.1440.1210.0790.1330.1580.0990.1220.1250.1790.1020.1030.1390.1120.1030.170.1290.1010.101
EPS 0.290.280.30.570.280.340.230.270.390.290.230.230.360.290.210.150.390.260.110.160.230.30.140.210.190.230.110.160.240.170.110.260.160.110.11
EPS Diluted 0.290.280.30.550.280.340.230.270.380.280.230.230.360.290.210.150.390.260.110.160.230.30.140.210.190.230.110.160.240.170.110.260.160.110.11
EBITDA 34.83636.13238.78632.58336.12142.1429.2432.74244.31636.01324.7424.17837.27732.86123.82620.43343.20228.8659.79117.01922.46332.01313.83735.53417.84924.91911.67711.83915.25412.8989.93720.16411.2888.418.41
EBITDA Ratio 0.1330.1470.1850.1230.1670.1540.130.1170.1690.1550.1240.0910.1690.1450.1360.0930.2020.1840.1210.0970.1470.1970.1150.2350.1370.2180.1240.1140.1360.1360.1490.210.1480.1260.126